(PharmaNewsWire.Com, January 10, 2017 ) According to the report “Asia pacific Regenerative Medicines”, published by Market Data Forecast, the market is projected to reach USD 10.71 billion by 2021, at a CAGR of 28.90% from 2016 to 2021.
Regenerative medicines repair, restore or regenerate human cells, tissues, or organs affected because of injury, disease, aging processes, congenital defects, and damage due to trauma. These medicines restore normal functions of cells & tissues. Regenerative Medicines Market are accessible in different types such as genes, somatic cells, stem cells, and other types. Some of these medicines have the ability to proliferate, segregate thereby restoring the original structure of cells or tissues or organs. Maximum of the researchers point to focus on the enhancement of new technologies to provide more finer regenerative medicines and productive healthcare treatment solutions to patients.
Regenerative medicines market is expected to observe growth owing to increasing demand for biologically derived materials for regenerative medicine, enhancing technological advancements, and rich support from government to encourage the tissue engineering for the enhancement of advanced therapies. In addition, expanding utilization of regenerative medicines in cancer research & drug discovery, inclining organ transplantations, and rising healthcare expenditure are further stimulating the expansion of regenerative medicines market.
Asia pacific market for regenerative medicines is segmented on the basis of product, therapy, and application On the basis of Product • Cell-Based products • Autologous Cell-Based Products • Allogeneic Cell-Based Products • Acellular Products On the basis of Therapy • Cell Therapy • Gene Therapy • Tissue Engineering • Immunotherapy On the basis of Application • Orthopedic & Musculoskeletal Spine • Dermatology • Cardiovascular • Central Nervous System • Oncology • Diabetes • Other Applications On the basis of Country • China • India • Japan • South Korea • Australia
The key players in regenerative medicines market such as, Vertex Pharmaceuticals Incorporated (U.S.), Acelity L.P. Inc. (U.S.), Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc. (U.S.), NuVasive, Inc. (U.S.), Vericel Corporation (Genzyme) (U.S.), Japan Tissue Engineering Co., Ltd. (Japan), Cytori Therapeutics Inc. (U.S.), Advantagene, Inc. (U.S.), and Mesoblast Ltd. (Australia).
• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: